NBIS closed at $153.27 on October 26, down 3.45% from $158.74, on 30.43M shares that were 1.43x the 20-day average of 21.32M and 1.53x the 60-day average of 19.83M, and the session's shape matters far more than the close: the stock opened at $153.97, rallied to $165.86 - above the broken $160.25 reversal low and above the October 23 high of $162.99 - then reversed and settled at $153.27, in the bottom quartile of a $16.37 (10.68%) range and below the October 22 low of $155.73. That is a failed reclaim of resistance followed by a fresh closing low for the move on expanded volume, on a day when the Nasdaq rose 0.82%, the S&P 500 gained 0.70% and the fell 5.45% to 18.39, so the weakness is idiosyncratic de-rating rather than beta. The descending-high sequence is now $178.85 (October 21) to $167.50 (October 22) to $165.86 (October 26), against descending lows of $164.00, $155.73 and $149.49. Price has closed below the at $173.09 for a seventh consecutive session and sits 11.45% beneath it, 25.83% below the at $206.65 and 24.31% below the at $202.50, while the / spread compressed to 19.39% from 20.34% - roughly 17 sessions from a death cross at the current ~$2-per-day convergence, which lands just after the November 10 report. Momentum is extended rather than repaired: the line printed a fresh low of -18.247 against a signal of -12.392 even as the histogram improved for a third straight session to -5.855, and (14) fell to 28.76, its first sub-30 close, making a lower low alongside price with no positive divergence. dropped the full 30.43M of volume to -40.80M, keeping the distribution signature intact. Fundamentals are unchanged and still strong at the top line - 453.99% revenue growth, a 74.26% gross margin, a 19.04% margin and $5.26B of operating cash flow - against free cash flow of -$9.61B, a -23.07% FCF yield, $8.04B of cash below $10.20B of debt, and 30.75x trailing sales with a 176.99x . Sell-side posture remains constructive in aggregate (mean $281, +83.3%; median $302, +97.0%; 2 strong buy, 13 buy, 6 hold, 1 sell) but those targets are stale, and Piper Sandler's October 21 cut to $185 now implies only +20.7%. With earnings 14 days away, 18.93% of float short, a 2.98-day cover ratio and at 10.41% of price, the setup is a binary event trade sitting on a broken chart. Net: HOLD on the franchise, SELL on the one-month, and no new capital before the November 10 print or a confirmed reclaim of $165.86 followed by the .
Decision
Live price
$168.73
Recommendation score
37%
37%
Confidence
67%
67%
Outlook by horizon
1M
SELL
Near
6M
HOLD
Mid
1Y
HOLD
Long
Primary catalyst
The November 10 earnings report, now 14 days away per the bundle's day count, is the single most market-moving item: with 18.93% of float short, a 2.98-day cover ratio and equal to 10.41% of price, a single guidance line on utilization, contract conversion or the funding plan can move the stock 15-25% in either direction, and it arrives with price at a fresh closing low of $153.27, having been rejected 4.7% below the October 22 high of $167.50 and with no NBIS-specific news in the feed since September 30 to anchor expectations.
Existing holders should already be at or below half of a normal risk-budgeted position, and the October 26 close at $153.27 below the broken $155.73 level keeps the technical case for adding firmly on hold ahead of the November 10 print. Fresh exposure should be limited to roughly 10-20% of a normal risk-budgeted position and only after either (a) a daily close back above $165.86 that holds for two sessions with volume above the 20-day average of 21.32M, or (b) the post-earnings reaction on November 10 - sized so that a 20-25% adverse gap is survivable given at 10.41% of price, 76.09% realized 20-day volatility, at 18.39 and 18.93% of float short. Do not average down into the event: at 28.76 and a crowded short base are bounce fuel, not a floor, and the October 16 oversold print at 30.63 was followed by an 18% decline.
Thesis Snapshot
Why It Works
The bull case is that the fundamental inputs in the bundle never deteriorated while the multiple collapsed: 453.99% year-over-year revenue growth, a 74.26% gross margin, a 19.04% margin and $5.26B of operating cash flow are all intact, yet the stock is 48.89% below its $299.86 high and trades at 30.75x sales, with the 10-year yield at 4.986% and down 5.45% to 18.39 - the macro tape actually improved on October 26 even as the stock fell. (14) at 28.76 is now outright oversold, 18.93% of float is short against a 2.98-day cover ratio, and the long-term structure is still technically alive with the 19.39% above a flattening and price 108.47% above its $73.52 52-week low. The October 26 session, read charitably, shows a genuine $11.89 intraday thrust from the open to $165.86 that cleared the $160.25 reversal low and the $162.99 October 23 high before being sold - proof that a bid exists above the market and that a short-covering impulse is available. Coverage is expanding into the weakness, with 15 of 22 ratings bullish and Rosenblatt ($304), Truist ($355), BNP Paribas ($399) and William Blair all constructive, leaving a $281 mean target (+83.3%) and a $302 median (+97.0%). The prior $174-183 exit zone remains 13.5-19.4% above spot and the prior $139 stop has not been triggered by a close. If the November 10 print validates contract conversion, utilization and a credible funding plan, the setup is a 49%-drawn-down, 19%-short high-growth name with no fundamental deterioration - precisely the configuration that produces violent squeezes, and the reward-to-risk on a small starter tranche would be strongly asymmetric.
What Breaks It
The bear case is that the stabilization the prior analysis hoped for was explicitly offered and explicitly rejected on October 26. NBIS gapped down to $153.97, rallied 7.7% to $165.86 - clearing both the $160.25 reversal low and the $162.99 October 23 high - and then gave the entire move back to close at $153.27, below the October 22 low of $155.73, in the bottom quartile of a 10.68% range, on 30.43M shares (1.43x the 20-day average) with falling the full day's volume to -40.80M. That is a failed breakout and a distribution day, and it happened on a session when the Nasdaq rose 0.82% and the S&P 500 rose 0.70%, which means investors are not being paid for beta here - they are being punished for idiosyncratic exposure. The structure is unambiguous: seven consecutive closes below the at $173.09, price 11.45% beneath it, 25.83% below the and 24.31% below the , at a fresh low of -18.247 against a -12.392 signal, at 28.76 making a lower low with price and no positive divergence, and an / spread compressing from 20.34% to 19.39% that puts a death cross roughly 17 sessions out - just after earnings. Nothing about self-funding has improved: free cash flow is -$9.61B against a -23.07% FCF yield, cash of $8.04B sits below $10.20B of debt, operating cash flow of $5.26B covers debt at only 0.52x, and the plan still requires $20-25B of 2026 capex plus ATM and convertible issuance - which becomes progressively more expensive to execute at $153.27 than at $250, and each further 10% decline makes the next ATM tranche 10% more dilutive. At 30.75x sales and 176.99x there is no earnings floor, forward is -42.60x, and the 2027 out-year estimate of -$6.15734 is far worse than -$5.64857 thirty days ago and -$4.86714 ninety days ago. The +83.3% to +97.0% analyst upside is stale, struck when the stock traded 25-45% higher; the one fresh print, Piper Sandler at $185 on October 21, now implies only +20.7%, and the $84 low target sits 45.2% below spot. With 14 days to a binary earnings event, a 10.41% , at 18.39 and 18.93% of float short, investors are being asked to underwrite gap risk with no cash cushion, a fresh closing low, and a failed rally as the only recent evidence.
For the near-term bearish call, the hard invalidation is a daily close above the October 22 high of $167.50 followed by a reclaim of the at $173.09 and the October 21 high at $178.85 on volume above the 20-day average of 21.32M, which would signal the entire October 14-26 decline was a final shakeout rather than a trend change - note that the October 26 rally stalled only $1.64 below that $167.50 trigger, so the level is live. For the longer-term franchise thesis, the invalidation is a daily close below $145 that is not recovered within two sessions, which would confirm a structural de-rating of the AI capex funding model with no tested support beneath. At the fundamental level, the thesis breaks either way on November 10: decelerating revenue growth, contract cancellations, or a funding plan that requires equity issuance at these prices would confirm the bear case, while validated pricing power and a credible self-funding path would invalidate it.
Funding and dilution risk: free cash flow of -$9.61B against $8.04B of cash, $10.20B of total debt and $2.15B of net debt, with the prior analysis recording $20-25B of planned 2026 capex, 12.7M Q2 ATM shares issued for about $2.8B and a $5.75B August convertible; the bundle's $41.67B market cap implies roughly 271.9M shares versus 238.4M reported, so the true diluted share count cannot be verified and per-share dilution risk is likely understated in headline metrics - and each 10% decline in the share price makes further ATM issuance 10% more dilutive.
Event risk into November 10: earnings are 14 days away, is 10.41% of price, 20-day realized volatility is 76.09%, and 18.93% of float is short with a 2.98-day cover ratio; the October 14-16 sequence alone produced consecutive sessions of 10%+ moves and October 26 produced a 10.68% intraday range, so a single guidance line can produce a 15-25% gap in either direction.
Valuation and estimate risk: 30.75x trailing sales, 176.99x , a -23.07% FCF yield and a -42.60x forward leave no cushion if growth decelerates, while the 2027 out-year estimate deteriorated to -$6.15734 from -$4.86714 ninety days ago, Piper Sandler cut its target 21.9% to $185 on October 21, and the analyst low target of $84 sits 45.2% below spot within a 4.88x high/low dispersion.
Relative-strength and positioning risk: NBIS fell 3.45% on a day the Nasdaq rose 0.82%, the S&P 500 rose 0.70% and the fell 5.45% to 18.39, so the drawdown is idiosyncratic and shows no sign of the beta-driven mean reversion that would rescue a high-beta name in a normal risk-on bounce; the stock is 48.89% below its 52-week high yet sits at only the 35.23rd percentile of its 52-week range, and the direction of short-interest change is not supplied, so crowded positioning could unwind violently in either direction.
Watch Next
Next earnings: Nov 10, 2026
The November 10 earnings report, now 14 days away per the bundle's day count, is the single most market-moving item: with 18.93% of float short, a 2.98-day cover ratio and equal to 10.41% of price, a single guidance line on utilization, contract conversion or the funding plan can move the stock 15-25% in either direction, and it arrives with price at a fresh closing low of $153.27, having been rejected 4.7% below the October 22 high of $167.50 and with no NBIS-specific news in the feed since September 30 to anchor expectations.
Signal Dashboard
Decision inputs
6 signals
Fundamental
83.3%
Upside to analyst mean target
At $153.27 and a reported market capitalization of $41.67B, NBIS trades at 30.75x trailing sales, 176.99x , 119.74x trailing , 4.06x price-to-book and -42.60x forward . The negative forward multiple confirms consensus FY estimates remain loss-making, which invalidates both the forward and the reported 0.3553 as valuation anchors, and the 3.13% net profit margin means the 119.74x trailing rests on a tiny and unstable earnings base. Enterprise value of $45.66B is 1.10x market capitalization, reflecting $2.15B of net debt, or -5.17% of market cap. With a -23.07% free-cash-flow yield there is no cash-based floor, and no peer or historical multiple series is supplied in this bundle, so relative cheapness cannot be established here. The most that can be said quantitatively is that the stock is 48.89% below its $299.86 52-week high while still 108.47% above its $73.52 low, sitting at the 35.23rd percentile of its 52-week range, and that 30.75x sales still demands the 453.99% growth rate persist and eventually convert into durable cash earnings. One data caveat: reported shares outstanding of 238.4M multiplied by $153.27 implies roughly $36.5B, versus the $41.67B stated market cap, which implies roughly 271.9M shares - a 14% gap consistent with stale or multi-class share data, so per-share valuation math should be treated as approximate. This is a narrative-and-duration valuation, not a cash-flow valuation, and the 10-year yield at 4.986% remains a mechanical headwind for the multiple.
Technical
Bearish
Trend quality
NBIS closed at $153.27 on October 26, down 3.45%, after trading from $153.97 up to $165.86 and back down to $149.49 - a 10.68% intraday range that closed in the bottom quartile and below the October 22 low of $155.73, producing a fresh closing low for the move. The rally attempt pierced the broken $160.25 reversal low and the October 23 high of $162.99 but stalled $1.64 short of the October 22 high of $167.50, so the descending-high sequence now reads $178.85 (October 21) to $167.50 (October 22) to $165.86 (October 26) against descending lows of $164.00 to $155.73 to $149.49. Price has closed beneath the at $173.09 for a seventh consecutive session and sits 11.45% below it, 25.83% below the at $206.65 and 24.31% below the at $202.50, with both intermediate averages still rolling over ( from $206.43 to $202.50, from $208.83 to $206.65 in one session). The remains 19.39% above the ($206.65 versus $173.09) so the multi-year golden-cross alignment persists, but the spread compressed from 20.34% as the gap narrowed from $35.54 to $33.56 in a single session; at roughly $2 of convergence per day a death cross is about 17 sessions out, landing just after the November 10 report. Overhead references are $155.73 (broken October 22 low), $160.25 (broken reversal low), $162.99 (October 23 high), $165.86 (October 26 high), $167.50 (October 22 high) and the at $173.09. Below today's low of $149.49 the supplied 30-session dataset contains no tested support, with the prior $145-150 volatility zone the only reference.
Earnings
14d
Improving
The most recent report (quarter ended 2026-06-30) delivered of -$0.68 versus -$0.86333 expected, a 21.24% beat, alongside bundle revenue growth of 453.99% year over year and a 74.26% gross margin; the improvement is real but modest in absolute terms, and two of the last four quarters missed (Q4 FY25 -$0.9865 versus -$0.605, a 63.06% miss, and Q3 FY25 -$0.475 versus -$0.395, a 20.25% miss), with no post-report share-price reaction supplied in the bundle. The Improving label reflects near-term estimate direction only: 0q, +1q and 0y are better than 30 and 60 days ago and one upward revision occurred in each series over the last thirty days (one for 0y and +1y in the last seven), but those near-quarter estimates remain worse than ninety days ago and the 2027 out-year estimate has deteriorated to -$6.15734 from -$4.86714 ninety days ago, the period in which the full depreciation and financing load lands; the mean surprise of roughly +59.3% is skewed by Q1 FY26's +396.1% one-time item, so the median surprise of about +10.7% is the better guide. Management credibility cannot be established from six quarters of mixed data. The next print on November 10, 2026 is 14 days away per the bundle's day count and is the sole near-term catalyst.
News
Mixed-Bearish
Headline tone
The November 10 earnings report, now 14 days away per the bundle's day count, is the single most market-moving item: with 18.93% of float short, a 2.98-day cover ratio and equal to 10.41% of price, a single guidance line on utilization, contract conversion or the funding plan can move the stock 15-25% in either direction, and it arrives with price at a fresh closing low of $153.27, having been rejected 4.7% below the October 22 high of $167.50 and with no NBIS-specific news in the feed since September 30 to anchor expectations.
Macro
Neutral
4.99% 10Y / 18.4 VIX
at 18.39 sits inside the neutral 15-20 band after a 5.45% decline, the 10-year Treasury yield is 4.986% and all four major indices closed higher (S&P 500 +0.70%, Nasdaq +0.82%, Dow +0.28%, Russell 2000 +0.38%), which removes the broad market as an alibi for a 1.46-beta name and makes NBIS's -3.45% session a pure relative-weakness signal rather than a beta event.
Stability
High-Beta Growth
Tactical Trade
NBIS pairs genuine franchise momentum (453.99% year-over-year revenue growth, a 74.26% gross margin, a 19.04% margin and $5.26B of operating cash flow) with a balance sheet that is still externally funded: free cash flow of -$9.61B, a -23.07% FCF yield, $8.04B of cash against $10.20B of debt, -$2.15B of net cash, and a prior-plan record of $20-25B of 2026 capex plus ATM and convertible issuance. Realized 20-day volatility is 76.09%, (14) is $15.95 or 10.41% of the $153.27 close, beta is 1.46, and 18.93% of float is short against a 2.98-day cover ratio, so a further 25-40% peak-to-trough drawdown inside a single quarter is a structural feature rather than a tail event; the stock is already 48.89% below its 52-week high. The still-intact -above- alignment (19.39% spread) and the intact demand narrative support a Medium durability tag, but the October 26 failed rally to $165.86 and close at $153.27 below the October 22 low of $155.73, the negative free-cash-flow conversion and the binary November 10 print mean this belongs in a satellite sleeve at a fraction of normal size, entered only on confirmed stabilization and sized for an adverse earnings gap.
Analyst Spread
Mean Target
$281.00
High / Low
$84 / $410
Median Target
$302.00
Consensus range
$84 - $410
— analysts
Mean
$84$281$410
Consensus
The $281 mean target implies +83.3% from $153.27 and the $302 median implies +97.0%, but this is almost entirely mechanical, reflecting the 35.42% one-month decline rather than any new sell-side information. The $84 low target (-45.2%) and $410 high target (+167.5%) produce a 4.88x dispersion that makes the mean a weak valuation anchor for a name with 76.09% realized volatility and -$9.61B of free cash flow. Coverage is expanding as the stock trades 48.89% below its high (22 current ratings versus 17 three months ago), which is usually a constructive medium-term signal, but the analyst-count field is null so breadth cannot be cross-checked. The bullish targets are underwritten by AI demand and pricing power; the bearish low target is underwritten by capex, financing and competition. Critically, the October 8 Rosenblatt initiation at $304, the September 9 Truist initiation at $355 and the BNP target of $399 were struck when NBIS traded 25-45% higher and have not been marked down, so they are stale reference points rather than support; the only fresh print, Piper Sandler's cut to $185 on October 21, now implies just +20.7% and is 34.2% below the mean.
Positioning Pulse
Insider Signal
Neutral
Net Bias
Sell-heavy
Insider Own.
3.4%
Institutional Own.
70.0%
Interpretation
The activity is directionally sell-heavy but immaterial in size and coded ambiguously, so it does not support an inference of discretionary management pessimism; with transaction codes missing, these could equally be 10b5-1 plan dispositions or vesting-related sales, and no conclusion about near-term management conviction can be drawn from a 0.026%-of-market-cap sample that has not changed in four weeks.
Notable activity
Three Form-4 rows are supplied, all with blank transaction-type fields and truncated day-of-month dates: Officer Andrey Korolenko disposing of 33,871 shares valued at about $7.97M, and Director John Boynton with two separate entries of 5,812 shares at about $1.47M each. Combined reported value is roughly $10.92M, or about 0.026% of the $41.67B market capitalization. No open-market purchases appear in the feed, and the sample is unchanged from the prior bundle, so no new insider information was added this period.
Market Context
Industry
Internet Content & Information
Bearish
Sentiment
-36
Tracked names
4
Grouping
industry
Internet Content & Information industry is currently Bearish with an average recommendation score near 45. capital and conviction are fading across the group, and leadership is concentrated in GOOGL, META, PINS.
Rotation Drivers
Average recommendation deltas are rolling over across Internet Content & Information industry, which points to capital rotating away from the group.
0 names are rated bullish versus 0 bearish names, keeping the group tone bearish.
Leadership is concentrated in GOOGL, META, PINS, so those names are the cleanest read on group-level capital rotation.
NBIS's economically relevant sector remains AI cloud and GPU data-center infrastructure, with NVIDIA upstream, hyperscalers acting as both customers and credible self-build competitors, and CoreWeave the closest public peer. The demand inputs in the bundle are intact: 453.99% year-over-year revenue growth, a 74.26% gross margin, a 19.04% margin and $5.26B of operating cash flow, and the Zacks coverage of September 29-30 points to Anthropic's 2025 revenue growing 1,088% to roughly $4.6B as evidence that compute demand is still compounding. The equity expression, however, has been repriced hard and is still falling: $249.87 on October 6 gave way to $153.27 on October 26, a roughly 38.7% decline in 14 sessions, a -35.42% one-month return and a -48.89% distance from the 52-week high. The theme is not fading fundamentally, but its highest-beta, cash-burning proxies remain the funding source for the rest of the market, and October 26 made that explicit - the Nasdaq rose 0.82% while NBIS fell 3.45%.
NBIS failed a reclaim of the $160.25 reversal low on October 26, spiking to $165.86 before closing at a fresh low of $153.27 on 1.43x average volume - a market-up day that this name spent underperforming badly.
Demand-side fundamentals in the bundle still support the theme: 453.99% revenue growth, a 74.26% gross margin, a 19.04% margin and $5.26B of operating cash flow, with the prior analysis citing more than $40B of contracted commitments and a 5GW year-end power target as forward visibility.
Positioning is moving the other way: a -48.89% distance from the 52-week high, a -35.42% one-month return, a -26.09% year-to-date return and 1.43x/1.53x of the 20-day and 60-day average volume on a down close after a failed rally, showing capital is exiting the highest-beta AI infrastructure expression.
Michael Burry's rotation from NBIS common shorts into 2027-dated puts keeps an institutional bear narrative attached to the theme even after the stock has already fallen 48.89% from its high.
The October 26 index tape was constructive rather than defensive - Nasdaq +0.82%, S&P 500 +0.70% - so this is not a growth-to-value rotation but a single-name de-rating, which is a more damaging signal for the theme's weakest balance sheets.
AI Capex Sustainability and Bubble Debate
Score: -55
Bearish
The most active narrative surrounding NBIS is no longer demand but who funds it. Burry closed common shorts in Micron, NBIS, Caterpillar, SOXX, CoreWeave, NVIDIA and Palantir and replaced most with longer-dated puts extending into 2027, explicitly linking Anthropic's roughly $4.6B of 2025 revenue to heavy infrastructure spending and a large accounting-related loss. NBIS sits squarely inside that debate with -$9.61B of free cash flow, a -23.07% FCF yield, $2.15B of net debt and a -42.60x forward , at a moment when the stock has lost 48.89% from its high while revenue growth is still 453.99% - the market is de-rating the funding model, not the demand. The theme strengthened again on October 26 as NBIS reversed a 7.7% intraday rally into a 3.45% loss while the broad indices rose.
NBIS closed at $153.27 on October 26 below the October 22 low of $155.73 despite an intraday spike to $165.86, while the Nasdaq gained 0.82% - funding skepticism is now surviving even a benign macro tape.
Burry's disclosed repositioning into 2027 puts across the AI complex, including NBIS, after weekend research accelerated his timeline for an AI bubble break.
Valuation-driven de-rating evidence within NBIS itself: the stock is 48.89% below its 52-week high while revenue growth is still 453.99%, and it fell another 3.45% on October 26 after a 7.23% drop on October 22 - the multiple is compressing on capital-intensity doubts, not only on discount rates.
The 2027 out-year estimate deteriorated to -$6.15734 from -$4.86714 ninety days ago, precisely the period in which depreciation and financing costs land, which is the numerical core of the funding-sustainability argument.
Piper Sandler's October 21 target cut to $185 from $237 is the first sell-side markdown dated after the October 14-20 collapse and now implies only +20.7%, signaling the funding debate is being priced into published estimates rather than just trading flow.
Key Stats
23 metrics total
Market Cap
$41.67B
P/E (TTM)
119.7
Forward P/E
-42.6
Revenue Growth
454.0%
ROE
0.6%
Beta
1.46
Full Metric Set
17 additional stats
Valuation Stack
Multiples and cash-flow framing.
Price / Sales
30.7
Price / Book
4.1
EV / EBITDA
177.0
Quality & Balance Sheet
Margins, leverage, and liquidity.
Gross Margin
74.3%
Operating Margin
-0.2%
Debt / Equity
98.6
Current Ratio
4.03x
Quick Ratio
3.61x
Positioning & Range
Short interest and 52-week location.
Short % Float
18.9%
Short Ratio
2.98x
52W High
$299.86
52W Low
$73.52
From 52W High
-48.9%
From 52W Low
108.5%
Company Classification
Sector and industry context.
Sector
Communication Services
Industry
Internet Content & Information
Additional Signals
Free Cash Flow
$-9614650368.00
Detailed Analysis
Valuation
At $153.27 and a reported market capitalization of $41.67B, NBIS trades at 30.75x trailing sales, 176.99x , 119.74x trailing , 4.06x price-to-book and -42.60x forward . The negative forward multiple confirms consensus FY estimates remain loss-making, which invalidates both the forward and the reported 0.3553 as valuation anchors, and the 3.13% net profit margin means the 119.74x trailing rests on a tiny and unstable earnings base. Enterprise value of $45.66B is 1.10x market capitalization, reflecting $2.15B of net debt, or -5.17% of market cap. With a -23.07% free-cash-flow yield there is no cash-based floor, and no peer or historical multiple series is supplied in this bundle, so relative cheapness cannot be established here. The most that can be said quantitatively is that the stock is 48.89% below its $299.86 52-week high while still 108.47% above its $73.52 low, sitting at the 35.23rd percentile of its 52-week range, and that 30.75x sales still demands the 453.99% growth rate persist and eventually convert into durable cash earnings. One data caveat: reported shares outstanding of 238.4M multiplied by $153.27 implies roughly $36.5B, versus the $41.67B stated market cap, which implies roughly 271.9M shares - a 14% gap consistent with stale or multi-class share data, so per-share valuation math should be treated as approximate. This is a narrative-and-duration valuation, not a cash-flow valuation, and the 10-year yield at 4.986% remains a mechanical headwind for the multiple.
Balance Sheet
Total cash of $8.04B against total debt of $10.20B leaves approximately $2.15B of net debt, a cash-to-debt ratio of 0.79x and debt-to-equity of 98.60% (roughly 0.99x, in the moderate band). Near-term liquidity is strong with a current ratio of 4.03 and a quick ratio of 3.61. Operating cash flow is positive at $5.26B but covers debt at only 0.52x, and free cash flow is -$9.61B, meaning the deficit is capital expenditure on data-center, GPU and power capacity rather than operating inefficiency. of 0.60% and of -1.92% show returns on invested capital are not yet established. The balance sheet is not distressed, but it is not self-funding either, and the prior analysis's record of 12.7M Q2 ATM shares issued for about $2.8B plus a $5.75B August convertible means funding remains an ongoing rather than a solved problem - a fact that matters more, not less, after a 48.89% drawdown that makes further equity issuance progressively more expensive.
Growth
The bundle's revenue growth field reads 4.5399, interpreted as 453.99% year over year, paired with a 74.26% gross margin, a 19.04% margin, a 3.13% net profit margin and a still-marginally-negative -0.22% operating margin. Earnings growth year over year is null in the supplied fundamentals and no sequential revenue series is provided, so a quarter-over-quarter growth trajectory cannot be computed. The critical structural fact remains the roughly 19.26 percentage point gap between the 19.04% margin and the -0.22% operating margin: that gap is depreciation, power and financing burden arriving ahead of revenue recognition, and it is exactly what the deteriorating 2027 out-year estimate of -$6.15734 (versus -$5.64857 thirty days ago, -$4.65857 sixty days ago and -$4.86714 ninety days ago) is capturing. Growth is exceptional and unverified at the returns-on-capital level simultaneously.
Business Quality
A 74.26% gross margin and a 19.04% margin are high-quality characteristics for an infrastructure business and support the proposition that NBIS is not a commodity capacity lessor. Liquidity ratios of 4.03 and 3.61, institutional ownership of 70.0% and insider ownership of 3.40% round out a credible ownership and liquidity profile. The counterweight is profitability quality: -0.22% operating margin, -1.92% and 0.60% indicate the business has not yet demonstrated it can earn an attractive return after depreciation, power, land and cost of capital. The bundle classifies NBIS under Communication Services / Internet Content & Information, which remains a poor description of the operating risks; the economically relevant sector is AI cloud and GPU data-center infrastructure, where capital intensity and power procurement, not content monetization, drive returns. Business quality is promising but unproven at the returns-on-capital level required to defend 30.75x sales.
Capital Allocation
Cash of $8.04B versus $10.20B of debt (0.79x coverage) and roughly $2.15B of net debt frame a capital plan funded partly by balance-sheet capacity and partly by external markets. Operating cash flow of $5.26B is entirely consumed and exceeded by the investment program, producing -$9.61B of free cash flow. The prior analysis records $20-25B of planned 2026 capex, roughly 70% upfront customer payments on Q2 deals expected to cover 50-60% of associated capex, a $775M GPU-asset-backed facility, 12.7M Q2 ATM shares issued for about $2.8B and a $5.75B August convertible; the current bundle does not update ATM terms or quantify subsequent dilution. Dividend yield and payout ratio are both 0.0, so there is no return-of-capital offset to issuance risk. Reported shares outstanding are 238.4M with a 228.69M float, while the stated $41.67B market cap at $153.27 implies roughly 271.9M shares, so per-share value creation cannot be verified precisely and remains unproven until incremental capacity earns above its funding cost.
Estimate Revisions
Estimate momentum has stabilized at the near end while deteriorating at the out-year, and the October 26 bundle adds no new revision information. In the current bundle 0q is -$1.238 versus -$1.4025 seven days ago, -$1.46 thirty days ago, -$1.53 sixty days ago and -$1.12333 ninety days ago; +1q is -$1.7775 versus -$2.00667, -$2.03, -$2.50667 and -$1.89; 0y is -$2.11316 and unchanged over seven days versus -$2.51833 thirty days ago, -$2.35667 sixty days ago and -$2.13667 ninety days ago; and +1y is -$6.15734 and unchanged over seven days versus -$5.64857 thirty days ago, -$4.65857 sixty days ago and -$4.86714 ninety days ago. The important nuance is that 0q and +1q improved off their 30-60 day lows but remain worse than ninety days ago, while the 2027 out-year estimate has deteriorated materially over both thirty and ninety days - the periods in which depreciation and financing costs land are being cut even as the current quarter stabilizes. The revision counters show one upward and one downward revision in thirty days for each of 0q, +1q, 0y and +1y, with one upward revision in the last seven days for 0y and +1y. Sell-side posture remains broadly stable: 15 of 22 current ratings are bullish (2 strong buy, 13 buy) with 6 hold, 1 sell and 0 strong sell, versus 14 of 21 a month ago (2 strong buy, 12 buy, 5 hold, 1 sell, 1 strong sell) and 12 of 17 three months ago. Dated actions include Piper Sandler maintaining Neutral on October 21 while cutting its target to $185 from $237 (the only action dated after the October 14-20 selloff and therefore the only current-cycle marker), Rosenblatt initiating Buy at $304 on October 8, William Blair initiating Outperform on September 30, BNP Paribas upgrading to Outperform and raising its target to $399 from $260 on September 24, and Rothschild initiating Sell at $84 on September 21. Note that the bundle's aggregate upgrade/downgrade counters read zero even though five dated actions are listed, an internal inconsistency that limits how much weight should be placed on the summary counts.